WordNet

write a computer program (同)programme
a performance (or series of performances) at a public presentation; "the program lasted more than two hours" (同)programme
a system of projects or services intended to meet a public need; "he proposed an elaborate program of public works"; "working mothers rely on the day care program" (同)programme
an announcement of the events that will occur as part of a theatrical or sporting event; "you cant tell the players without a program" (同)programme
(computer science) a sequence of instructions that a computer can interpret and execute; "the program required several hundred lines of code" (同)programme, computer_program, computer programme
arrange a program of or for; "program the 80th birthday party" (同)programme
any of various squash plants grown for their elongated fruit with smooth dark green skin and whitish flesh (同)marrow squash, vegetable_marrow
the fatty network of connective tissue that fills the cavities of bones (同)bone_marrow
very tender and very nutritious tissue from marrowbones (同)bone_marrow
large elongated squash with creamy to deep green skins (同)vegetable_marrow
person who makes a gift of property (同)giver, presenter, bestower, conferrer
(medicine) someone who gives blood or tissue or an organ to be used in another person (the host)
the head of an organized crime family (同)father

PrepTutorEJDIC

髄(ずい),骨髄 / 精髄,粋 / 力,活力
寄付者,寄贈者 / (移植用の組織・器官の)提供者,献血者
《Don》ドン(Sirに当たるスペイン語で男性の洗礼名の前につける) / 〈C〉スペイン貴族(紳士) / 〈C〉(オックスフォード・ケンブリッジ両大学の)学監,指導教授 / 〈C〉《英》大学教師
〈衣服〉‘を'着る,〈帽子〉‘を'かぶる[do onの短縮形]

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 造血細胞移植のドナーの評価 evaluation of the hematopoietic cell transplantation donor
2. 造血細胞移植のためのドナー選定 donor selection for hematopoietic cell transplantation
3. 造血細胞移植後のQOL quality of life following hematopoietic cell transplantation
4. 造血細胞移植のための臍帯血の収集および保存 collection and storage of umbilical cord blood for hematopoietic cell transplantation
5. 造血幹細胞の分布 sources of hematopoietic stem cells

Estimating KIR Haplotype Frequencies on a Cohort of 10,000 Individuals: A Comprehensive Study on Population Variations, Typing Resolutions, and Reference Haplotypes.

Vierra-Green C1, Roe D2,3, Jayaraman J4, Trowsdale J4, Traherne J4, Kuang R3, Spellman S1, Maiers M2.
PloS one.PLoS One.2016 Oct 10;11(10):e0163973. doi: 10.1371/journal.pone.0163973. eCollection 2016.
The killer cell immunoglobulin-like receptors (KIR) mediate human natural killer (NK) cell cytotoxicity via activating or inhibiting signals. Although informative and functional haplotype patterns have been reported, most genotyping has been performed at resolutions that are structurally ambiguous.
PMID 27723813

Reduced Intensity Conditioned Allograft Yields Favorable Survival for Older Adults with B-cell Acute Lymphoblastic Leukemia.

Rosko A1, Wang HL2, de Lima M3, Sandmaier B4, Khoury HJ5, Artz A6, Brammer J7, Bredeson C8, Farag S9, Kharfan-Dabaja M10, Lazarus HM11, Marks DI12, Martino Bufarull R13, McGuirk J14, Mohty M15, Nishihori T10, Nivison-Smith I16, Rashidi A17, Ringden O18,19, Seftel M20, Weisdorf D21, Bachanova V22, Saber W2.
American journal of hematology.Am J Hematol.2016 Oct 6. doi: 10.1002/ajh.24575. [Epub ahead of print]
Older adults with B-cell acute lymphoblastic leukemia (B-ALL) have poor survival. We examined the effectiveness of reduced intensity conditioning (RIC) hematopoietic cell transplant (HCT) in adults with B-ALL age 55 years and older and explored prognostic factors associated with long-term outcomes.M
PMID 27712033

National Institutes of Health Blood and Marrow Transplant Late Effects Initiative: the Healthcare Delivery Working Group Report.

Hashmi SK1, Bredeson C2, Duarte RF3, Farnia S4, Ferrey S5, Fitzhugh C6, Flowers ME7, Gajewski J8, Gastineau D1, Greenwald M9, Jagasia M10, Martin P11, Rizzo JD12, Schmit-Pokorny K13, Majhail NS14.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.Biol Blood Marrow Transplant.2016 Oct 3. pii: S1083-8791(16)30388-3. doi: 10.1016/j.bbmt.2016.09.025. [Epub ahead of print]
Hematopoietic cell transplantation (HCT) survivors are at risk for development of late complications and require lifelong monitoring for screening and prevention of late effects. There is an increasing appreciation of the issues related to healthcare delivery and coverage that are faced by HCT survi
PMID 27713091